Compare KALU & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KALU | HAE |
|---|---|---|
| Founded | 1946 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.8B |
| IPO Year | 2006 | 1996 |
| Metric | KALU | HAE |
|---|---|---|
| Price | $187.17 | $77.29 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $147.33 | $84.13 |
| AVG Volume (30 Days) | 216.8K | ★ 991.1K |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.78% | N/A |
| EPS Growth | ★ 135.89 | N/A |
| EPS | ★ 3.71 | 2.05 |
| Revenue | ★ $1,585,900,000.00 | $910,373,000.00 |
| Revenue This Year | $13.37 | N/A |
| Revenue Next Year | $2.62 | $5.23 |
| P/E Ratio | $48.98 | ★ $37.86 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $71.44 | $47.32 |
| 52 Week High | $195.22 | $87.32 |
| Indicator | KALU | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 52.97 | 66.34 |
| Support Level | $172.51 | $48.98 |
| Resistance Level | $194.82 | $81.99 |
| Average True Range (ATR) | 8.14 | 3.47 |
| MACD | -1.06 | -0.33 |
| Stochastic Oscillator | 48.03 | 61.76 |
Kaiser Aluminum Corp specializes in the production of semi-fabricated specialty aluminum mill products, such as aluminum plate and sheet, bare and coated coil and extruded and drawn products, for the end market applications: Aero/HS Products; Packaging; GE Products; and Automotive Extrusions. Its products include fabricated aluminum mill products such as flat-rolled (plate, sheet, and coil), extruded (rod, bar, hollows, and shapes), drawn (rod, bar, pipe, tube and wire) and certain cast aluminum products. Geographically, the company generates majority of its revenue from the United States.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.